期刊文献+

注射用唑来膦酸治疗恶性肿瘤骨转移性疼痛67例临床观察 被引量:12

Clinical observation of zoledronic acid in the treatment of pain of bone metastasis caused by maligent tumor
下载PDF
导出
摘要 目的:观察注射用唑来膦酸治疗恶性肿瘤骨转移性疼痛的效果和不良反应。方法:67例恶性肿瘤骨转移性疼痛的患者,每次给予唑来膦酸注射液4mg,用生理盐水100ml稀释后静脉滴注,每3-4周1次,至少连续2次。结果:止痛效果:显效23.9%(16/67),有效46.2%(31/67),总有效率70.1%,活动能力总改善率64.2%(43/67),生活质量改善总有效率65.6%(44/67)。主要不良反应为发热、一过性肌肉骨关节痛、流感样症状等,反应轻,不需特殊处理。结论:唑来膦酸注射液能明显减轻恶性肿瘤骨转移性疼痛和显著提高患者的生活质量。 Objective:To observe the efficacy and adverse effect of zoledronic acid injection for the pain relief in patients with metastatic bone cancer.Methods:Sixty seven patients with osseous metastasis pain were treated with zoledronic acid injection.Two cycles of zoledronic acid injection were used.Results:The effect of pain relief: remarkable effective rate was 23.9%(16/67),effective rate was 46.2.2%(31/67).Main adverse effects were febricity,temporary muscle and skeletal pain.All of the adverse effects did not require medical interfere.Conclusion:Zoledronic acid injection can relieve the pain and improve life quality for the patients with osseous metastasis pain.
出处 《现代肿瘤医学》 CAS 2010年第10期2044-2046,共3页 Journal of Modern Oncology
关键词 唑来膦酸 骨转移性疼痛 疗效 不良反应 Zoledronic acid pain of osseous metastasis efficacy adverse effect
  • 相关文献

参考文献9

  • 1Coleman RE.Skeletal complications of malignancy[J],Cancer,1997,80:1588-1594.
  • 2Saad F,Olsson C,Schulman CC.Skeletal morbidity in men with prostate cancer:quality-of-life considerations throughout the continous of care[J].EurUrol,2004,46:731-739.
  • 3Kimmel DB.Mechanism of action pharmacokinetic and pharmacodynamic profile,and clinical applications of nitrogen-contaning bisphosphonates[J].J Dent Res,2007,86(11):1022-1033.
  • 4Tassone P,Tapliaferri P,Viscomi C,et al.Zoledronic acid induces antiproliferative and apoptotic effect in human pancreatic canaer cells in vitro[J].Br J Cancer,2003,88(12):1971-1978.
  • 5Croucher PI,De Hendrik R,Perry Mj,et al.Zoledronic acid treatment of 5T2MM-bearing mice inhibits the development of myeloma bone disease:evidence for decreased osteolysis,tumor burden and angiogenesis and increased survival[J].J Bone Miner Res,2003,18(3):482-492.
  • 6Ferretti G,Fabi A,Carlini P,et al.Zoledronic acid and angiogenesis[J].Clin Cancer Res,2007,13(22Pt1):6850-6851.
  • 7Dieli F,Gebbia N,Poccia G,et al.Induction of gammsdelta T-lymphocyte effector functions by bisphosophonate zoledronic acid in cancer patients in vivo[J].Blood,2003,102(6):2310-2311.
  • 8Thomas JP,Vladimir M.Zoledronic acid in the management of metastatic bone disease[J].Ther Clin Risk Manag,2008,4:261-268.
  • 9Kawada K.A multicenter and open label clinical trial of zoledronic acid 4mg in patients with hypercalcemia of malignancy[J].Jpn J Clin Oncol,2005,35(1):28-33.

同被引文献151

引证文献12

二级引证文献104

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部